Here we employed a series of human glioma cell lines to test the content and distribution of oncogenic epidermal growth factor receptor (EGFR) including its mutant (EGFRvIII) among different subsets of tumour-derived EVs. The gene discussed is EGFR; the disease is central nervous system cancer.